| Selective α7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes S Sydserff, EJ Sutton, D Song, MC Quirk, C Maciag, C Li, G Jonak, ... Biochemical pharmacology 78 (7), 880-888, 2009 | 118 | 2009 |
| Low level lead exposure increases sensitivity to the stimulus properties of dopamine D1 and D2 agonists DA Cory-Slechta, DV Widzowski Brain research 553 (1), 65-74, 1991 | 70 | 1991 |
| Homogeneity of regional brain lead concentrations. DV Widzowski, DA Cory-Slechta Neurotoxicology 15 (2), 295-307, 1994 | 69 | 1994 |
| Postnatal lead exposure induces supersensitivity to the stimulus properties of a D2-D3 agonist DA Cory-Slechta, MJ Pokora, DV Widzowski Brain research 598 (1-2), 162-172, 1992 | 59 | 1992 |
| Long-term functional end points following middle cerebral artery occlusion in the rat TJ Hudzik, A Borrelli, P Bialobok, D Widzowski, S Sydserff, A Howell, ... Pharmacology Biochemistry and Behavior 65 (3), 553-562, 2000 | 57 | 2000 |
| Therapeutic Combinations S Breining, J Evenden, E Johnson, K Jordan, S Letchworth, C Miller, ... US Patent App. 11/855,175, 2008 | 50 | 2008 |
| Time course of postnatal lead-induced changes in dopamine receptors and their relationship to changes in dopamine sensitivity. DV Widzowski, JN Finkelstein, MJ Pokora, DA Cory-Slechta Neurotoxicology 15 (4), 853-865, 1994 | 47 | 1994 |
| Behavioral manifestations of prolonged lead exposure initiated at different stages of the life cycle: II. Delayed spatial alternation. DA Cory-Slechta, MJ Pokora, DV Widzowski Neurotoxicology 12 (4), 761-776, 1991 | 42 | 1991 |
| Quetiapine and its metabolite norquetiapine: translation from in vitro pharmacology to in vivo efficacy in rodent models AJ Cross, D Widzowski, C Maciag, A Zacco, T Hudzik, J Liu, S Nyberg, ... British journal of pharmacology 173 (1), 155-166, 2016 | 39 | 2016 |
| Unique mechanism of action for the antidepressant properties of the atypical antipsychotic quetiapine JM Goldstein, G Christoph, S Grimm, JW Liu, D Widzowski, M Brecher Biological Psychiatry 61 (8), 124S-125S, 2007 | 39 | 2007 |
| Lead retards development of Drosophila melanogaster J Cohn, DV Widzowski, DA Cory-Slechta Comparative Biochemistry and Physiology Part C: Comparative Pharmacology 102 …, 1992 | 37 | 1992 |
| Pharmacological inhibition of PARP6 triggers multipolar spindle formation and elicits therapeutic effects in breast cancer Z Wang, SE Grosskurth, T Cheung, P Petteruti, J Zhang, X Wang, W Wang, ... Cancer research 78 (23), 6691-6702, 2018 | 35 | 2018 |
| Low affinity use-dependent NMDA receptor antagonists show promise for clinical development GC Palmer, D Widzowski Amino acids 19 (1), 151-155, 2000 | 35 | 2000 |
| Effects of nicotinic agonists and antagonists on spatial working memory in normal adult and aged rats DV Widzowski, E Cregan, P Bialobok Drug development research 31 (1), 24-31, 1994 | 34 | 1994 |
| Functional alterations in dopamine systems assessed using drug discrimination procedures. DA Cory-Slechta, DV Widzowski, MJ Pokora Neurotoxicology 14 (2-3), 105-114, 1993 | 34 | 1993 |
| Food conditioning and prey selection by young yellow perch (Perca flavescens) EL Mills, DV Widzowski, SR Jones Canadian Journal of Fisheries and Aquatic Sciences 44 (3), 549-555, 1987 | 29 | 1987 |
| Apparent mediation of the stimulus properties of a low dose of quinpirole by dopaminergic autoreceptors. DV Widzowski, DA Cory-Slechta Journal of Pharmacology and Experimental Therapeutics 266 (2), 526-534, 1993 | 25 | 1993 |
| PW01-27-Translational pharmacology of quetiapine and norquetiapine: preclinical findings support multifunctional psychotropic properties S Nyberg, D Widzowski European Psychiatry 25 (S1), 25-E1429, 2010 | 22 | 2010 |
| Preclinical pharmacology and pharmacokinetics of AZD3783, a selective 5-hydroxytryptamine 1B receptor antagonist M Zhang, D Zhou, Y Wang, DL Maier, DV Widzowski, CD Sobotka-Briner, ... Journal of Pharmacology and Experimental Therapeutics 339 (2), 567-578, 2011 | 20 | 2011 |
| D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]‐MNPA, [3H]‐(+)‐PHNO, and [3H]‐raclopride T Peng, J Zysk, P Dorff, CS Elmore, P Ström, J Malmquist, M Ding, D Tuke, ... Synapse 64 (8), 624-633, 2010 | 18 | 2010 |
thomas hudzikALA BioPharma ConsultingVerified email at alacgroup.com
